US-based Bio-Techne, a manufacturer of life science reagents, instruments and services for the research, diagnostic and bioprocessing markets, has announced the opening of a new facility in Dublin, Ireland.
The 2,300m2 site will better position the company to serve academic and biopharma customers across Europe and will serve as the region’s primary distribution hub.
In a press release, chief executive officer Chuck Kummeth said: “This additional geographical hub reflects Bio-Techne’s commitment to the European research community, as well as expectations for continued growth and success within the EMEA region. This new facility provides Bio-Techne additional support and resilience to its EMEA supply chain operations for years to come.”
Naomi Davies is an FDI consultant at Investment Monitor, with expertise in location benchmarking and cross-border investment.